| Q40596242 | Analysis of Immune Epitopes of Respiratory Syncytial Virus for Designing of Vectored Vaccines Based on Influenza Virus Platform. |
| Q37200211 | CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance |
| Q39328222 | Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo. |
| Q37351948 | Discovery of common marburgvirus protective epitopes in a BALB/c mouse model |
| Q36922491 | Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope |
| Q37252640 | In situ evolution of virus-specific cytotoxic T cell responses in the lung |
| Q35382696 | Major histocompatibility complex-dependent cytotoxic T lymphocyte repertoire and functional avidity contribute to strain-specific disease susceptibility after murine respiratory syncytial virus infection |
| Q47238680 | Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection. |
| Q35635434 | Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates |
| Q37721415 | Prospects for defined epitope vaccines for respiratory syncytial virus |
| Q34089255 | Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope |
| Q89861770 | TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine |
| Q30423530 | The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus |